High-throughput Analysis of ANRIL CircRNA Isoforms in Human Pancreatic Islets
Affiliations
The antisense non-coding RNA in the INK locus (ANRIL) is a hotspot for genetic variants associated with cardiometabolic disease. We recently found increased ANRIL abundance in human pancreatic islets from donors with certain Type II Diabetes (T2D) risk-SNPs, including a T2D risk-SNP located within ANRIL exon 2 associated with beta cell proliferation. Recent studies have found that expression of circular species of ANRIL is linked to the regulation of cardiovascular phenotypes. Less is known about how the abundance of circular ANRIL may influence T2D phenotypes. Herein, we sequence circular RNA in pancreatic islets to characterize circular isoforms of ANRIL. We identify several consistently expressed circular ANRIL isoforms whose expression is correlated across dozens of individuals and characterize ANRIL splice sites that are commonly involved in back-splicing. We find that samples with the T2D risk allele in ANRIL exon 2 had higher ratios of circular to linear ANRIL compared to protective-allele carriers, and that higher circular:linear ANRIL was associated with decreased beta cell proliferation. Our study points to a combined involvement of both linear and circular ANRIL species in T2D phenotypes and opens the door for future studies of the molecular mechanisms by which ANRIL impacts cellular function in pancreatic islets.
Kettunen S, Suoranta T, Beikverdi S, Heikkila M, Slita A, Raty I Cells. 2024; 13(11.
PMID: 38891115 PMC: 11171903. DOI: 10.3390/cells13110983.
ANRIL: A Long Noncoding RNA in Age-related Diseases.
Wang R, Yuan Q, Wen Y, Zhang Y, Hu Y, Wang S Mini Rev Med Chem. 2024; 24(21):1930-1939.
PMID: 38716553 DOI: 10.2174/0113895575295976240415045602.
ANRIL, H19 and TUG1: a review about critical long non-coding RNAs in cardiovascular diseases.
da Cunha Agostini L, Almeida T, Silva G Mol Biol Rep. 2023; 51(1):31.
PMID: 38155319 DOI: 10.1007/s11033-023-09007-x.
The Long Non-Coding RNA ANRIL in Cancers.
Sanchez A, Lhuillier J, Grosjean G, Ayadi L, Maenner S Cancers (Basel). 2023; 15(16).
PMID: 37627188 PMC: 10453084. DOI: 10.3390/cancers15164160.